Fridays vs GoodRx
GoodRx costs $100 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
If you are choosing between Fridays and GoodRx, the first difference is cost: GoodRx is $100 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 5.5.
Fridays vs GoodRx price
GoodRx is the cheaper way in: $149 a month against $249 a month at Fridays. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.
Drug by drug: Tirzepatide is cheaper at GoodRx ($299 a month vs $359 a month).
Medications and formats
Both sell tirzepatide; only Fridays lists semaglutide; only GoodRx lists orforglipron.
On format, Fridays prices compounded injections and brand-name pens, while GoodRx prices brand-name pens.
Where each one treats patients
Fridays does not publish where it ships, and GoodRx lists 50 states.
Pricing
Fridays
GoodRx
What each price covers
Fridays' price also covers the clinician visit, the medication itself and coaching, which GoodRx does not claim.
Fridays is silent on shipping and lab work.
GoodRx does not say what its price includes.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
GoodRx
Inclusions not disclosed.
Where each one scores higher
Overall, GoodRx scores 6.9 and Fridays 5.5 out of 10.
Fridays is stronger on support (7.0 vs 5.0).
GoodRx is stronger on value (5.0 vs 2.8), user experience (5.0 vs 3.0), trust & safety (6.0 vs 4.0) and accessibility (10.0 vs 5.0).
Effectiveness is within half a point.
Fridays
5.5/10
GoodRx
6.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Fridays nor GoodRx has an FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | GoodRx |
|---|---|---|
| Starting Price | $249/mo | ✓$149/mo |
| Features | 2 features | ✓6 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
GoodRx wins this one, 6.9 to 5.5, above all for oral orforglipron alongside the injectables. It also costs $100 less each month than Fridays. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Fridays vs GoodRx: FAQ
Close alternatives to Fridays and GoodRx
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- GoodRx vs Found
- GoodRx vs Kin Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.